Mangoceuticals Inc (MGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 84 | 168 | 109 | 105 | 133 |
| Cost of Goods | 33 | 78 | 47 | 25 | 51 |
| Gross Profit | 51 | 90 | 62 | 80 | 83 |
| Operating Expenses | 7,627 | 5,437 | 4,963 | 1,783 | 1,891 |
| Operating Income | -7,543 | -5,269 | -4,853 | -1,678 | -1,758 |
| Interest Expense | 76 | 22 | -14 | -451 | 242 |
| Other Income | 0 | -126 | 0 | -722 | 0 |
| Pre-tax Income | -7,619 | -5,416 | -4,840 | -1,949 | -2,000 |
| Net Income Continuous | -7,619 | -5,416 | -4,840 | -1,949 | -2,000 |
| Minority Interests | -1 | 0 | 0 | 2 | -1 |
| Net Income | $-7,618 | $-5,416 | $-4,840 | $-1,950 | $-1,999 |
| EPS Basic Total Ops | -0.69 | -0.57 | -1.29 | -0.83 | -1.14 |
| EPS Basic Continuous Ops | -0.66 | -0.54 | -1.05 | -0.53 | -0.99 |
| EPS Diluted Total Ops | -0.69 | -0.57 | -1.29 | -0.83 | -1.14 |
| EPS Diluted Continuous Ops | -0.66 | -0.54 | -1.05 | -0.53 | -0.99 |
| EPS Diluted Before Non-Recurring Items | -0.69 | -0.57 | -1.29 | -1.01 | -0.99 |
| EBITDA(a) | $-7,518 | $-4,432 | $-4,438 | $-1,420 | $-1,546 |